Clinical Trial

Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Patients with STEMI (ST-segment elevation myocardial infarction) with multivessel disease which have PCI (percutaneous coronary intervention)-suitable non-IRA (infarct related artery) will be randomized to immediate complete revascularization group or staged revascularization group by 1:1 fashion. Non-IRA lesion which have equal or more than 70% diameter stenosis by visual estimation will be revascularized without FFR (fractional flow reserve) evaluation. Non-IRA lesion with diameter stenosis 50-70% by visual estimation will be evaluated using FFR device. In case of FFR value more than 0.8, non-IRA lesion wll be deferred without PCI. If FFR value was equal or less than 0.8, non-IRA lesion will be revascularized.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-11-06; most recent amendment 2026-07-04.
Status change: Recruiting → Active, Not Recruiting 2024-01-21
Trial Details
NCT Number NCT04626882
Lead Sponsor Chonnam National University Hospital
Conditions Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis
Enrollment 994 participants
Start Date 2019-12-30
Primary Completion 2025-01-15 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07